Search

Randall L. Beane

Examiner (ID: 450, Phone: (571)270-3457 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1675, 1654
Total Applications
610
Issued Applications
172
Pending Applications
104
Abandoned Applications
347

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10050823 [patent_doc_number] => 09090691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences' [patent_app_type] => utility [patent_app_number] => 13/822435 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9333 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822435 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/822435
Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences Sep 14, 2011 Issued
Array ( [id] => 8892448 [patent_doc_number] => 20130165632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'METHOD FOR SEPARATING WATER-SOLUBLE BIOLOGICAL SUBSTANCES' [patent_app_type] => utility [patent_app_number] => 13/820898 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6843 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820898 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/820898
METHOD FOR SEPARATING WATER-SOLUBLE BIOLOGICAL SUBSTANCES Sep 8, 2011 Abandoned
Array ( [id] => 9831935 [patent_doc_number] => 08940751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications' [patent_app_type] => utility [patent_app_number] => 13/821481 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17490 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1023 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821481 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/821481
Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications Sep 8, 2011 Issued
Array ( [id] => 9263211 [patent_doc_number] => 20130345140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'Basement Membrane Compositions and Applications Thereof' [patent_app_type] => utility [patent_app_number] => 13/818904 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7559 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818904 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/818904
Basement Membrane Compositions and Applications Thereof Aug 24, 2011 Abandoned
Array ( [id] => 9197634 [patent_doc_number] => 20130336950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES' [patent_app_type] => utility [patent_app_number] => 13/820377 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5630 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820377 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/820377
MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES Aug 18, 2011 Abandoned
Array ( [id] => 8301925 [patent_doc_number] => 20120184482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Novel Ubiquitin-Isopeptide Probes' [patent_app_type] => utility [patent_app_number] => 13/213667 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5777 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13213667 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/213667
Novel Ubiquitin-Isopeptide Probes Aug 18, 2011 Abandoned
Array ( [id] => 8842224 [patent_doc_number] => 20130137852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/813831 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813831 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/813831
NOVEL COMPOUNDS AS DPP-IV INHIBITORS AND PROCESS FOR PREPARATION THEREOF Aug 2, 2011
Array ( [id] => 11304813 [patent_doc_number] => 09512199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Fibronectin cradle molecules and libraries thereof' [patent_app_type] => utility [patent_app_number] => 13/813409 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 70 [patent_no_of_words] => 56856 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813409 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/813409
Fibronectin cradle molecules and libraries thereof Jul 31, 2011 Issued
Array ( [id] => 8951272 [patent_doc_number] => 20130197053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/810729 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810729 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/810729
PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE Jul 5, 2011 Abandoned
Array ( [id] => 8607117 [patent_doc_number] => 20130012429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'ANTI-VIRAL THERAPY' [patent_app_type] => utility [patent_app_number] => 13/176994 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11664 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13176994 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/176994
ANTI-VIRAL THERAPY Jul 5, 2011 Abandoned
Array ( [id] => 7670056 [patent_doc_number] => 20110319325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'MULTI-COMPONENT PHARMACEUTICALS FOR TREATING DIABETES' [patent_app_type] => utility [patent_app_number] => 13/169740 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13809 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169740 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/169740
MULTI-COMPONENT PHARMACEUTICALS FOR TREATING DIABETES Jun 26, 2011 Abandoned
Array ( [id] => 8749474 [patent_doc_number] => 08415307 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-04-09 [patent_title] => 'Antibiotic compositions for the treatment of gram negative infections' [patent_app_type] => utility [patent_app_number] => 13/167495 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10812 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167495 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/167495
Antibiotic compositions for the treatment of gram negative infections Jun 22, 2011 Issued
Array ( [id] => 8278439 [patent_doc_number] => 20120172313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'TREATMENT OF PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/166960 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 23112 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166960 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/166960
TREATMENT OF PROLIFERATIVE DISEASES Jun 22, 2011 Abandoned
Array ( [id] => 8916354 [patent_doc_number] => 20130177979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'METHODS AND COMPOSITIONS FOR CELL PERMEABLE STAT3 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/806639 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31313 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806639 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/806639
METHODS AND COMPOSITIONS FOR CELL PERMEABLE STAT3 INHIBITOR Jun 21, 2011 Abandoned
Array ( [id] => 8964063 [patent_doc_number] => 20130203665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'SINGLE-CHAIN INSULIN AGONISTS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/701146 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 72905 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701146 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/701146
Single-chain insulin agonists exhibiting high activity at the insulin receptor Jun 15, 2011 Issued
Array ( [id] => 9162027 [patent_doc_number] => 20130310304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/704477 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10626 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704477 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/704477
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS Jun 14, 2011 Abandoned
Array ( [id] => 11799839 [patent_doc_number] => 09540634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Transcriptome in vivo analysis' [patent_app_type] => utility [patent_app_number] => 13/702415 [patent_app_country] => US [patent_app_date] => 2011-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12717 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702415 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/702415
Transcriptome in vivo analysis Jun 6, 2011 Issued
Array ( [id] => 8733716 [patent_doc_number] => 20130079285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/700623 [patent_app_country] => US [patent_app_date] => 2011-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16313 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700623 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/700623
SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME May 29, 2011 Abandoned
Array ( [id] => 9401719 [patent_doc_number] => 08691771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Bi-specific fusion proteins for tissue repair' [patent_app_type] => utility [patent_app_number] => 13/112907 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14807 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112907 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112907
Bi-specific fusion proteins for tissue repair May 19, 2011 Issued
Array ( [id] => 8854128 [patent_doc_number] => 20130143803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'Process for the Preparation of Insulin-Zinc Complexes' [patent_app_type] => utility [patent_app_number] => 13/696897 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8654 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696897 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/696897
Process for the Preparation of Insulin-Zinc Complexes May 8, 2011 Abandoned
Menu